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Background: Following stroke, many people have difficulty activating their paretic muscles quickly and with sufficient
power to regain their balance by taking quick and effective steps. Reduced dynamic balance and mobility following
stroke, or ‘walking balance’, is associated with reduced self-efficacy and restrictions in daily living activities, community
integration, and quality of life. Targeted training of movement speeds required to effectively regain balance has been
largely overlooked in post-stroke rehabilitation. The Fast muscle Activation and Stepping Training (FAST) program
incorporates fast functional movements known to produce bursts of muscle activation essential for stepping and
regaining standing balance effectively. The purpose of this study is to: 1) compare the effectiveness of an outpatient
FAST program to an active control outpatient physiotherapy intervention in improving walking balance following
stroke, and 2) explore potential mechanisms associated with improvements in walking balance.
Methods/Design: This will be an assessor-blinded, parallel group randomized controlled trial design. Sixty participants
(30 per group) who have sustained a stroke within the previous six months will be randomly assigned with stratification
for lower limb motor recovery to receive twelve 45-minute 1:1 physiotherapy intervention sessions over 6 – 10 weeks in
an outpatient setting of either: 1) FAST intervention - systematic and progressive practice of fast squatting and stepping
exercises, or 2) active control - conventional physiotherapy directed at improving balance and mobility that includes no
targeted fast movement training. The same blinded research physiotherapist will assess outcomes at three time points:
1) baseline (prior to intervention), 2) follow up (within one week post-intervention); and 3) retention (one month
post-intervention). The primary outcome is dynamic balance assessed using the Community Balance and Mobility
Scale. We will also assess fast and self-selected walking speed, balance self-efficacy, and the ability to respond to
internal and external perturbations to balance and associated changes in postural muscle activation.
Discussion: The targeted training of fast functional movements in the FAST program is expected to improve
walking balance following stroke compared to the active control intervention. Unique to this study is the
investigation of potential mechanisms associated with improvements in walking balance.
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Balance ability is one of the most important factors in de-
termining independence in daily activities and risk of falls
following stroke [1]. Dynamic balance and mobility or
‘walking balance’ can be described as the ability to control
the centre of mass (COM) within the base of support to
remain upright during ambulation [2] and encompasses a
range of walking-related tasks which challenge the balance
system. The impact of diminished dynamic balance can be
significant for stroke survivors. The resulting mobility lim-
itations are associated with decreased self-efficacy, loss of
independence, and restrictions in activities of daily living,
community integration, and quality of life [3,4].
People following stroke struggle to produce sufficient
power (the product of force and speed) with their par-
etic muscles; deficits in speed of movement are well-
documented after stroke [5,6]. It has been suggested
that power may be more important than absolute force
production in functional mobility tasks, and velocity of
movement may be instrumental to counteract poten-
tially destabilizing forces exerted on an individual’s
COM by gravity and environmental interactions (exter-
nal perturbations) as well as voluntary movements (in-
ternal perturbations) [7,8]. Modest perturbations to
quiet stance can be accommodated using an inverted
pendulum model of balance control [9] in which the
ankle musculature plays a pivotal role in the mainten-
ance of stance, while activation of muscles around the
hips is essential in responding to larger perturbations
[10,11], particularly if a step is required to maintain
balance - termed a stepping reaction [12]. There may
be a greater reliance on stepping behaviours to avoid a
fall after stroke than in healthy individuals [13]; how-
ever, impairments in paretic muscle activation make it
difficult for these individuals to step with sufficient
speed, coordination and amplitude to effectively to re-
gain their balance [7,14,15].
Current clinical practice guidelines advocate task-
oriented exercise programs involving the practice of
‘real life tasks’ following stroke [16], but specificity of
task practice with respect to the speed required for pos-
tural reactions has received relatively little attention. A
single session of fast functional squat and stepping
training in stroke survivors has been found to improve
paretic muscle activation and postural responses during
an internal perturbation balance task after the exercises
[15,17]. A recent case series reported improvements in
walking balance that were retained for one year following
a 12-session stepping retraining program in community-
dwelling individuals with chronic stroke [18]. These
changes in balance were accompanied by an increase in
participation in meaningful activities in the community,
and improvements in the movement kinematics of step-
ping reactions. These findings suggest that Fast muscleActivation and Stepping Training (FAST) may be an effect-
ive approach to improve walking balance following stroke.
The primary objective of this assessor-blinded, parallel
design, randomized controlled trial is to investigate the ef-
fectiveness of an outpatient FAST program commenced
within the first six months following stroke compared to
an active control intervention of conventional outpatient
physiotherapy (active control) that includes no targeted
fast movement training for improving walking balance. As
many people fall in the first few months after discharge
from inpatient rehabilitation, this was thought to be an
important window for this balance intervention [19]. The
primary hypothesis is that improvements in walking
balance (as measured with the Community Balance and
Mobility Scale, CB&M [20,21]) will be larger following 12
sessions of FAST intervention compared to 12 sessions of
active control intervention. The secondary hypothesis is
that CB&M scores will continue to be higher in the FAST
group compared to the active control group one month
following the intervention. Another aim of this study is to
explore potential mechanisms associated with improve-
ments in walking balance including; improvements in
walking speed, balance self-efficacy, ability to respond to
internal and external perturbations to balance and associ-
ated changes in postural muscle activation. Ourmechanistic
hypotheses are that compared to the active control inter-
vention; the FAST retraining will result in:
a) Increased fast and self-selected natural walking
speed (gait assessment);
b) Reduced postural sway (balance perturbation
assessment);
c) Improved timing and amplitude of muscle activation
(EMG onset timing, burst area and slope) during
balance perturbations and gait;
d) Increased balance self-efficacy (using Activities-
specific Balance Confidence (ABC) scale).
Methods
Study design
The study is a single-blind, parallel design, randomized
controlled trial, with the assessor blinded to the group al-
location of the participants (Figure 1). The participants
cannot be blinded to the interventions that they receive,
though they will not be aware of the details of the other
study arm. Eligible participants who provide written
consent will be randomly assigned, to the FAST or ac-
tive control group. Interventions will be received fol-
lowing discharge from inpatient rehabilitation in the
outpatient departments of two hospitals in the Greater
Vancouver area; Holy Family and Lion’s Gate Hospitals.
Outcome measurements will be evaluated at the Univer-
sity of British Columbia at three time points (Figure 1): 1)
baseline (prior to the first intervention session), 2) follow
Figure 1 Design of the FAST Study. Flow chart illustrating study design from initial contact with potential participants to retention assessment.
CMSA, Chedoke-McMaster Stroke Assessment.
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3) and retention (one month following the 12th inter-
vention session) by the same blinded assessor. This
study was approved by the University of British
Columbia Human Research Ethics Committee. This
protocol is reported in accordance with SPIRIT guide-
lines [22,23].Selection criteria and recruitment of participants
Individuals who have had their first stroke (confirmed
by admission CT scan) within the previous 6-months
that resulted in unilateral hemiparesis and required in-
patient rehabilitation will be invited to participate if
they also meet the following inclusion criteria: Sufficient motor control in the paretic lower limb to
perform the stepping activities in the FAST
program: Chedoke McMaster Stroke Assessment
(CMSA) [24] leg and foot scored as stages 3–6
(stage 7 consider ‘normal’). CMSA leg and foot
scores reflect the presence and severity of motor
impairment following stroke, and they are used
clinically to evaluate motor recovery [25].
 Standing balance ability necessary to participate
safely in the FAST program: Berg Balance Score
(BBS) ≥ 30/56 [26]. The BBS has established validity
and excellent reliability in for assessing functional
balance in people following stroke [27].
 Cognitive capacity to provide informed consent:
Mini-Mental Status Examination score ≥ 24/30 [28].
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 Bilateral stroke or a history of previous stroke(s) for
which inpatient rehabilitation was received.
 Severe co-morbidities likely to dominate the pattern
of care (e.g. metastatic disease, severe congestive
heart failure, etc.), co-existing peripheral neuropa-
thies or vestibular disorders likely to independently
have a negative impact on balance, and severe mus-
culoskeletal problems or pain; as these conditions
would be likely to impede participation in the study
interventions.
 Global aphasia, receptive aphasia or language
barriers who do not have someone to assist them in
translating information, as these individuals would
have difficulty providing informed consent or
understanding exercise instructions.
The initial contact with potential participants will be
made by the inpatient physiotherapist who is treating the
potential participants at the two participating hospitals.
The physiotherapist will ask them if they are interested in
learning more about the study and, if interested, ask them
if they will give consent to have the research coordinator
review their chart to confirm eligibility. After reviewing
their chart, the research coordinator will approach the
prospective participant to describe the study in more de-
tail or explain why they are not eligible. The research co-
ordinator will review the letter of explanation and the
consent form with the prospective participant and answer
any questions. The research coordinator will return at
least 24 hours later to obtain written consent before par-
ticipating. Family members may be present to assist if
there are any language barriers. All patients admitted with
a primary diagnosis of stroke will be screened by their
physiotherapists at two hospitals using a screening check-
list. In accordance with CONSORT guidelines [29], the
number of screened patients who are ineligible (and the
reasons for ineligibility) or who are potentially eligible but
are not interested in the study will be recorded.
To optimize recruitment, all members of the stroke re-
habilitation teams at each recruitment site including
physiotherapy managers, site coordinators, intake clerks
and physiotherapists will be engaged in refining the pro-
cesses for screening and recruitment specific to their
organizations; strategies that are tailored to the sites
will be developed collaboratively including reminders,
flow charts for processes and communication, and
screening forms designed to minimize burden for the
site staff and their patients. These processes will be
reviewed and revised based on feedback and will be
sustained by onsite coordinators who serve as local
leaders and champions for the study in collaboration with
the research coordinator.Group allocation and data management
Data will be managed using web-based software (EmPower
Health Research, http://www.empowerhealthresearch.ca/).
Upon registration, the software assigns each participant a
unique identification number. Upon screening eligibility,
providing signed consent and completion of the baseline
assessment, participants will be randomized by the re-
search coordinator using the integrated randomization
software, “Integration”. This software protects allocation
concealment by ensuring screening is complete and the
participant is eligible prior to randomization as well as
preventing multiple allocation of the same participant or
unjustified removal of participants post-randomization.
Participants will be stratified by their (combined leg
and foot – affected limb only) CMSA score (≤8 or ≥9)
to force a balance between groups in the motor recov-
ery of the leg and foot. The randomization scheme is
set up in permuted blocks of 2 and 4 to ensure a simi-
lar number of participants between groups and to
prevent screening clinicians from guessing the next
allocation. All outcome data will be entered into Em-
Power by the research coordinator, and the accuracy of
data entry will be double-checked by a second person
who will be blinded to participant group allocation.
Research personnel who are to remain blind to group
allocation (outcome assessors, data analysts) will not
have access to the randomization form when they log
into the database to enter data. The data management
software contains an audit log that records the user
with date and time stamps for all data entries, changes
to data and explanations for changes. Data verification
and the audit trail ensure high standards of data integrity
and validity.
Intervention
Participants in both intervention groups will receive 12 in-
dividual 45-minute physiotherapy sessions. These sessions
are intended to be scheduled twice per week over a 6 week
time frame. A pragmatic window will be set for comple-
tion of the 12 sessions within 10 weeks to accommodate
interruptions (e.g. illness, vacations, etc.). This dosage is
established firstly, to be consistent with the estimated dos-
age of regular out-patient physiotherapy following stroke
reported by the two participating hospitals, thereby sup-
porting the potential external validity of the study, and
secondly, based on previous research reporting improve-
ments in community- level balance and mobility (assessed
by CB&M score), and in movement kinematics following
12 sessions of stepping reaction training in individuals
with chronic stroke [18].
FAST intervention program
The FAST intervention will involve the systematic and
progressive practice of fast functional movements to
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patory postural adjustments of the leg and trunk muscles
essential for regaining standing balance and community
mobility activities (Table 1) [7,15,17,30]. The treatment
physiotherapist providing the training will apply motor
learning principles, in particular, using the ‘challenge
point framework’ [31], previously applied successfully to
retrain stepping reactions in community-dwelling indi-
viduals following stroke [18]. Using this approach the
conditions of practice including the organization of
practice (e.g. blocked versus random practice schedules),
the level of physical support (e.g. use of a overhead har-
ness versus a walking belt with standby assistance of a
therapist), and the feedback provided (e.g. immediate
versus summary feedback) will be adjusted by the treat-
ment physiotherapist and progressed according to the
skill level of the performer and the relative difficulty of
the task to reach optimal ‘challenge points’ for learning
and skill transfer to balance disturbances in everyday life
[18,31].
The content of the FAST intervention program is pro-
vided in Table 1. The progression of exercise tasks will
be based on the clinical judgment of the treatment
physiotherapist in conjunction with the participant [18].
The exercises will include:
1. Squats: This exercise was associated with short term
improvements in muscle activation and postural
responses to balance perturbations in individuals
with chronic stroke [15,17]. Squats will be used as a
warm up activity and to encourage more equal
weight distribution between the paretic and non-
paretic legs. As participants improve, this squatting
task will be relatively easy to perform, and therefore
more time within the intervention session will be
spent performing the stepping activities.
2. Stepping: The progressive retraining of the quick
automatic stepping responses required to re-establish
balance following perturbations is the core element of
the FAST intervention. The stepping training activities
will be based on a previously published program used
with community dwelling individuals following stroke,
and adapted to the abilities of the subacute stroke par-
ticipant group [18]. Initially, participants will be per-
mitted to take as many additional steps as required to
regain their balance, but will later be instructed to
stop their momentum within 2–3 steps. This stepping
activity elicits fast bursts of muscle activation in the
stepping leg(s) and fast postural adjustments to alter-
ations in balance [15]. Step exercises will be performed
with both legs in all directions (forward, backward
and laterally to each side).
3. Complementary activities: Finally, additional
complementary activities will be provided to addchallenge and variety for high level participants who
quickly and easily complete the core step training
program within the individual intervention sessions.
These activities were selected as they were likely to
evoke fast bursts of muscle activation and quick steps
consistent with the goal of practicing fast lower limb
movements. They will include the option of a 4-square
exercise adapted from the clinical ‘4-square test’ of
stepping and change of direction [32], and more
challenging stepping and bounding [33] activities.
Active control program
Similar to the FAST intervention, the active control
intervention will include activities tailored to the individ-
ual needs and goals of the participant to regain balance
and mobility [34]. The content of the active control
physiotherapy intervention will include task-specific
practice of standing balance and walking activities, as
well as stretching, strengthening and endurance exer-
cises. The main difference in the treatment between ac-
tive control group and what might be delivered in
regular out-patient physiotherapy is that there will be no
specific training of fast stepping responses and no sys-
tematic training of fast over-ground walking (including
treadmill training). These activities are not typically part
of the conventional treatment provided at the two par-
ticipating hospitals. Additionally, there will be no train-
ing of bounding, hopping or other exercises that
emphasize high velocity contraction.
Concomitant care
During the study, participants will be advised not to
undertake concomitant specific balance and mobility
training or treatment. Participants will receive their
other outpatient treatment programs (e.g. occupational
therapy, speech-language therapy) and can engage freely
in community-based activities that may include aqua-
exercise, senior’s activity programs, etc.
Intervention fidelity and monitoring of adverse events
Treatment physiotherapists who will be delivering the
FAST and active control interventions will be provided
with a treatment handbook outlining the intervention
program. This material will be reviewed in a group train-
ing session with case examples and opportunities for dis-
cussion to provide feedback to refine and clarify the
written materials. During the study, the research coord-
inator, an experienced physiotherapist and clinical re-
searcher, will go to individual sites to facilitate the
implementation of the proposed interventions, providing
1:1 guidance specific to the knowledge and beliefs of the
treatment physiotherapists, their environment, and the
needs of their participants while still ensuring the critical
elements of the intervention are provided as planned [35].
Table 1 FAST intervention program content
1 Squats
Squats to approximately 30 degrees of hip and knee flexion “as fast as possible” to promote a sudden braking action.
Typical instruction: “Unlock your knees and stop the downward movement as quickly as possible.”
• Dosage: Work up to 5 sets of 10 reps. Allow approximately 5 s between each rep and 30 s (or longer) between each set
2 Steps
The core element of the FAST intervention, step training is to be included in every treatment session. Participants will lean, pivoting at their ankles
until they need to take protective step(s) to stop themselves from falling. A typical instruction is provided (below); however, treatment
physiotherapists will tailor instructions and feedback to the participant, based on their performance and abilities.
Typical instruction: “Lean [forward/backward/to the side] and let yourself fall like a tree until you feel like you are losing your balance. The goal is to take
steps that are long enough and fast enough that you are able to regain your balance.”
Progressions of step activities are listed below in increasing level of difficulty:
a. Simple blocked practice
Stepping leading with each leg in each direction is practiced in blocks of 10 reps.
• Dosage: Work up to 2 sets of 60 reps. Each set consists of 10 reps each of leading with paretic (P) and non-paretic (NP) leg leaning forward
and backward directions, and 10 reps each of lateral leaning to P and NP side (lead leg not specified).
b. Semi-random practice:
i. Stepping leading with each leg in each direction is practiced in blocks of 5 reps
• Dosage: 5 sets of 5 reps with each leg (or to each side for the lateral leaning task) in each direction (75 reps with each leg/to each side
in total)
ii. Stepping using alternate leading legs/leaning side (P then NP) each time, for a total of 10 reps (5 reps/side) forward, backward and laterally.
• Dosage: 5 sets of 10 reps (75 reps with each leg/to each side)
c. Random practice:
Stepping leading with the P leg in all 3 directions - forward, backwards, and laterally to P side, then leading with the NP leg in all 3 directions.
d. Random nomination of lead leg with reduced movement planning time:
Therapist randomly nominates the lead leg after leaning in the forward or backward direction has been initiated by the participant.
• Dosage: Target of 20 steps with P leg in the forward and backward directions (40 reps total).
e. Concurrent task planning:
Participants asked to perform a simple concurrent cognitive task (e.g. counting backwards from 10) as they lean and step. Start with the simple
blocked practice (2a) and progress to random practice (2c).
3. Complementary activities to add to challenge and interest:
a. Step over -4-square exercise: Masking tape will be affixed to the floor in a ‘+’ design creating 4 squares. The participant will begin with both feet
in a square facing forward, and move in a counterclockwise direction through each square in sequence until they reach the ‘start’ square; they
will than move in a clockwise direction to again return to the ‘start’ square [32]. The following instructions are given to the patient ‘try to
complete the sequence as fast as possible without touching the tape lines. Both feet must make contact with the floor in each square. If
possible, face forward during the entire sequence.’ Timing and accuracy can be used as feedback.
Progress – ask Participant to ‘bound’, rather than step over the pattern.
b. Additional stepping and bounding activities
i. Leaning and stepping off a Sissel Balancefit dome (or similar support)
ii. Stepping onto/off of a stable low block/step, progressing to bounding on/off block/step
iii. Bounding off one leg to land in a step-to position working toward a ‘flight phase’ with both feet off the ground, progress to bounding and
landing on the opposite foot.
For these exercises ‘shock absorption’ by the landing leg is to be emphasized (return to mini-squats to emphasize if necessary). Therapists will
monitor to insure any pre-existing musculoskeletal symptoms are not aggravated. Activities will be practiced first in a forward direction, then
progressing to lateral and then backwards directions; start with blocked practice (as in 2a), then progress to random practice schedule (as in 2c).
• Dosage: Work up to 60 repetitions with each leg/side
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developed with feedback from the treatment physiothera-
pists will be used to record the content and duration of
interventions provided to the participants. The number of
repetitions of activities, the level of assistance (overheadharness, transfer belt), scheduling of practice (blocked,
semi-random, random) and feedback (immediate, sum-
mary) will be recorded for each FAST intervention session.
Ongoing correspondence will be maintained with the
treatment physiotherapists to ensure that the interventions
Miller et al. BMC Neurology 2014, 14:187 Page 7 of 12
http://www.biomedcentral.com/1471-2377/14/187are being provided as planned, to share information be-
tween treatment physiotherapists, and to further revise and
clarify treatment information based on their feedback and
experience. Audit and feedback based on the recorded
treatment information will be used by the research coord-
inator to monitor and provide a post-hoc assessment of
the FAST implementation fidelity in terms of primary mea-
sures of content (Table 1) and minimum dosage (indicated
in ‘dosage’ for each activity, Table 1). The performance tar-
get is for all FAST participants to be capable of performing
the random nomination of lead leg activity (Table 1, Activ-
ity 2d) with the support of a walking belt and standby as-
sistance from a therapist by the end of the 12 sessions of
intervention period. Similarly the content of the active con-
trol intervention will be audited and feedback will be pro-
vided in those instances where fast movement related
interventions are documented. The individual onsite visits
will be used to provide a formative assessment and feed-
back to the treatment physiotherapists regarding the ex-
tent to which the individual treatment sessions match
with the intended intervention programs.
Participants entering the study will be warned that they
may experience exercise-related muscle discomfort 24–48
hours following the intervention sessions, as many partici-
pants will not have participated in vigorous physical activ-
ities recently. Any unanticipated or adverse events will be




Stroke specific information ✓
Medical information ✓
Mini-mental Status Exam ✓
Chedoke-McMaster Stroke Assessment leg & foot
score
✓
Berg Balance Scale ✓
Community Balance and Mobility Scale
Activities-specific Balance Confidence questionnaire
10 Metre Walk Test (fast walking speed)
Biodex – maximum voluntary contraction EMG
Self-selected walking speed
Gait – kinematic, kinetic and EMG parameters
Physiological Balance Test – Postural stress test
(external perturbations)
Physiological Balance Test – Arm raise task (internal
perturbations)
Physiological Balance Test – Stepping Reactions
(internal perturbations)
Helpfulness of treatment received in improving
balancehospital site and recorded in the EmPower data base, with
referral for appropriate medical follow up. As this is an
effectiveness study, the interventions will be modified to
accommodate co-existing conditions (e.g. ankle sprain)
and emerging issues (e.g. recovery from an acute respira-
tory infection).
Outcome assessment and data collection
A summary of the measures to be collected at four time
points (enrolment, baseline, follow up and retention) is
provided in Table 2. The research coordinator will ad-
minister and record the MMSE to establish eligibility.
The other clinical measures used to establish eligibility
(BBS, CMSA leg and foot scores) and descriptive data
including general demographic information (gender, age,
hand dominance), stroke-specific information (date of
stroke, type, side and location of stroke), co-morbidities
and past medical history will be collected from charted
information. Primary and secondary outcome measures
and associated information recorded at Baseline, Follow
up and Retention assessments will be conducted at
University of British Columbia by the same blinded
physiotherapy assessor. Participants will be asked to
wear the same shoes for all assessment sessions.
Reasons for missing outcome assessments or treat-
ment sessions will be recorded. Where possible, out-
comes will still be collected at planned time points,sment time points
Time 2: Baseline
assessment
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accordance with intention-to-treat analyses.
Primary outcome measure
Walking balance
The Community Balance and Mobility scale (CB&M)
was selected as the primary outcome measure to evalu-
ate change in walking balance [21]. The CB&M consists
of 19 test items scored from 0 to 5 (with the exception
of the stair descent item, scored/6) based on quality
and/or speed of performance, for a maximum score of
96 with higher CB&M scores reflecting better balance
and mobility performance. The CB&M demonstrates
strong responsiveness in community-dwelling individ-
uals following stroke relative to other commonly
employed clinical measures of balance such as the BBS,
which suffers from floor effects in this population [20].
Secondary outcome measures
Secondary clinical and laboratory-based measures will
be taken at all assessment sessions to explore mecha-
nisms for improvements in walking balance including;
improvements in fast and self-selected walking speed,
balance self-efficacy, ability to respond to internal and
external perturbations to balance and associated
changes in postural muscle activation. Satisfaction with
study interventions will also be evaluated.
Clinical and self-report measures
1. Fast walking speed: The average completion time
over three trials of the 10 metre walk test will be
used to determine ‘fast’ gait speed. Participants will
be instructed to, “Walk as quickly as possible while
still remaining safe” without a gait aid, if possible.
Should participants require a gait aid, the same gait
aid will be used in assessments at all time points.
This measure has established test-retest reliability in
individuals following stroke [36]. Gait speed provides
an indication of functional mobility and has been
shown to be sensitive to change in patients recover-
ing from stroke [37].
2. Self-reported confidence in balance activities: The
Activities-specific Balance Confidence Scale (ABC)
[38] is a self-reported questionnaire requiring partic-
ipants to rate their confidence in completing 16 ac-
tivities that challenge balance in the community
from 0 (no confidence) to 100 (very confident). This
measure has strong discriminant validity in identify-
ing individuals experiencing multiple falls following
stroke [39].
3. Satisfaction with physiotherapy interventions received
during the study: In response to the question:
“Please rate the usefulness of the treatment that youreceived for improving your balance”, participants
will rate interventions as 1 (not useful at all) to 5
(very useful) on a 5-point Likert scale.
Laboratory-based measures
Kinetics (force platform), kinematics (motion capture) and
electromyography (EMG) will be collected in all the
laboratory-based measures to investigate potential physio-
logical mechanisms linked to functional changes following
the FAST intervention. Kinetic, kinematic, and EMG data
will be synchronized and collected simultaneously using
commercially available software (Cortex, Motion Analysis
Corp.).
Data collection methods
Kinetic data will be collected using two floor-mounted
force platforms (OR6-6, Advanced Mechanical Tech-
nologies Inc.) sampling at 2000 Hz. Kinematic data will
be collected from 10 high-speed, high-resolution digital
cameras (Raptor-E, Motion Analysis Corp.) that sample
the movement of 22 reflective markers at 100 Hz. These
reflective markers will be affixed to the participant’s skin
according to a modified Helen Hayes marker set [40] bi-
laterally over the acromion processes, lateral epicondyles
of the elbows, radial styloid processes, anterior superior
iliac spines, lateral thighs, lateral femoral epicondyles,
lateral tibiae, lateral malleoli, posterior calcanei, and on
the ventral aspect of the feet over the bases of the 2nd
metatarsal. A single marker will be placed over the
sacrum. EMG data (Trigno™ Wireless EMG, Delsys Inc.)
will collected at 2000 Hz by wireless surface electrodes
placed bilaterally over the erector spinae, biceps femoris,
quadriceps femoris, soleus and tibialis anterior muscles.
The EMG data for each muscle group will be normalized
to the maximum EMG recorded during three 5 s max-
imal voluntary isometric contractions performed while
the participants are seated and secured onto the Biodex
Isokinetic dynamometer (Model 900–860, Biodex Med-
ical Systems, Inc.) using a methodology adapted from
Hsu et al. [41]. The follow laboratory-based measures
will be performed:
1. Self-selected walking speed: Participants will
complete five walking trials at a self-selected natural
pace along a 10 m walkway. Whole body COM will
be calculated throughout the trial based on the posi-
tions of the reflective markers and using published
anthropometric calculations [42]. Average walking
speed from each trial will be calculated over the
middle 4 m of the walkway based on the calculated
movement of the whole body COM separately for
the paretic and non-paretic lower limb. The overall
self-selected gait speed will be obtained by averaging
across the five trials [43].
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be fitted into a safety harness attached to the ceiling
and will stand (without assistive devices) with each
foot on a separate force platform during the
performance of the balance assessment tasks
described below. Foot position on the platform will
be standardized between outcome testing sessions
using the tracings of each foot on paper adhered to
the platforms. Participants will perform the
following assessments:
a. Quiet stance: Participants will be instructed to
look at a visual target and “stand as still as you
can”. Five 10 s trials will be recorded to
determine resting baseline EMG activation levels
for each muscle.
b. Limits of stability: Participants will be asked to
perform two maximal forward leans without
raising their heels, hold the forward lean position
for 5 s, and then return to their start position
[44].
c. External perturbations: A Postural Stress Test
adapted from Wolfson et al. [45] will be
performed. Participants will stand with their eyes
open focusing on a visual target at eye level while
a series of forward perturbation forces (1, 2, 3, 4,
and 5% of body weight) are exerted via a
horizontal cable attached to the participant’s hips
using a pulley system hidden behind a curtain.
Using this paradigm, it will be difficult for
participants to anticipate the timing of the
perturbations. Participants will be instructed to
“remain standing in place on the platforms.” The
onset of the load drop will be measured using an
accelerometer attached to the load being
dropped. The highest load tolerated without
taking a step will be repeated 5 times [46].
d. Internal Perturbations: Participants will be
instructed: “When you are ready, raise your arm
as fast as you can to shoulder height and hold it
there” as they focus on a visual target at eye
level [11]. Participants will perform 2–3 practice
trials to familiarize themselves with the task and
to receive any necessary correction on their
performance. Ten trials with rest periods of 3–
5 s between trials will be recorded. Arm
acceleration magnitude will be measured using
an accelerometer secured on the non-paretic
hand to quantify the magnitude of the
perturbation.
e. Stepping reactions: To evaluate change in
stepping performance, participants will be asked
to perform 5 blocked trials with each leg as the
lead stepping leg in the forward direction
[15,47].Analysis of mechanistic outcomes
The mechanistic outcomes from all the physiological bal-
ance tests will be the EMG characteristics (burst slope,
burst area and onset timing [11,17,48]) and displacement
of the whole body COM with respect to the centre of
pressure (CP) including postural sway. The calculation of
the COM using the motion capture software provides a
measure of whole body movement. During feet-in-place
tasks, CP displacement is representative of the body’s ac-
tive control of balance which aims to maintain the COM
safely within the base of support provided by the feet [49].
EMG onset timing, burst slope and area reflect the speed
and magnitude of activation of postural muscles in antici-
pation of, or in response to balance perturbations.
1. Centre of mass-centre of pressure (COM-CP) dis-
placement: The resultant ground reaction force data
will be used to calculate the CP. The antero-
posterior and medio-lateral coordinates of the COM
position and the CP will be calculated for each data
sample and used to calculate the resultant distance
between the COM and CP in the transverse plane
(COM-CP displacement). We will identify the max-
imum COM-CP displacement during each trial for
physiological balance activities 2 b-e. These parame-
ters will also be used to quantify postural sway in
quiet stance (activity 2a).
2. Timing of EMG onset: The onset of muscle
activation burst (in milliseconds) will be calculated
relative to the onset of the arm acceleration in the
internal perturbations, the onset of load release for
external perturbations, and onset of knee movement
of the stepping leg for stepping reactions [15] for
each trial.
3. EMG burst slope and area: The EMG burst area will
be calculated separately for each trial. The EMG
burst slope will be calculated from the average of
the repeated trials. These parameters will reflect the
timing and magnitude of the burst above quiet
stance state and will be normalized to maximum
EMG recorded on the Biodex.
Sample size
Data from our published study of a similar FAST train-
ing protocol in individuals with chronic stroke showed
an effect size of 1.9 SD with the intervention group and
a pooled standard deviation of 7.45 for the pre and post
CB&M score (primary outcome measure) [18]. Using
our pilot data and a sample size equation suitable for
our planned between-group comparisons using an ana-
lysis of covariance (ANCOVA); where we estimated that
the magnitude of the association between the pre- and
the post-intervention CB&M scores would be at least
0.75 and that a conservative estimate of effect size would
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participants in total) are required to maintain a Type I
error rate of 5% and 80% power to detect a difference
between intervention groups. Therefore, recruitment will
continue until a total of 30 participants in each group
have completed the follow up assessment.
Statistical analyses
The primary analysis will follow the intention to treat
(ITT) principle; such that, once the participants are ran-
domized they will be analyzed within their randomly
assigned group, regardless of compliance with the proto-
col. As part of the ITT analysis, participants will not be re-
moved from the analysis unless it can be shown that the
participant was ineligible prior to randomization (and
therefore should never have been included).
Primary analysis
We will perform an analysis of covariance (ANCOVA),
where the baseline CB&M score serves as the covariate;
treatment group as the independent variable, and the
follow up CB&M score as the dependent variable. To
test our secondary hypothesis about retention, we will
repeat this analysis with the retention CB&M score as
the dependent variable.
Analyses of mechanistic outcomes
We will conduct a similar analysis for all other continuous
outcome variables (maximal and self-selected walking
speed, EMG parameters, and COM-CP displacement, and
ABC score). Because our outcomes are related, we will
not adjust our alpha error rate, but rather, look for
consistency across outcomes. We will conduct an explora-
tory analysis to determine whether the variability in walk-
ing balance can be explained by the initial participant
characteristics (side of lesion, type of stroke, CMSA score,
initial ABC score, BBS score). To conduct these analyses,
we will use a step-wise least squares method of linear re-
gression where walking balance is the dependent variable,
the pre-test measurement is a covariate, and group is an
independent variable.
Dissemination plan
One of the collaborators in this study is a Knowledge
Broker, hired by the Department of Physical Therapy to
enhance knowledge translation. The Knowledge Broker
will augment the uptake of the research findings from
this current study in the clinical community. In addition
to publishing the results in high quality journals and
presenting findings at national and international confer-
ences, the results will be disseminated through the fund-
ing agency, The Heart and Stroke Foundation of BC and
Yukon, on their website. The authors also intend to
disseminate the information through talks to localorganizations including Stroke Recovery groups and will
make the FAST training program freely available for
download from the laboratory website.
Discussion
The goal of this study is to determine whether an indi-
vidualized physiotherapy exercise program geared to im-
proving the speed of muscle activation (FAST) and
incorporating motor learning principles is effective in
retraining walking balance in an outpatient population
following stroke. If effective, this novel exercise approach
has the potential to significantly improve the rehabilita-
tion strategies for walking balance, an activity which is
of paramount importance for individuals following
stroke. The study design and the intervention parame-
ters have been deliberately established to optimize the
generalizability the FAST program to other outpatient
stroke clinical settings. Unique to this study is the focus
not only on clinical effectiveness, but also mechanistic
outcomes to evaluate physiological changes in walking
and balance performance as well as perceived balance
self-efficacy.
Additional files
Additional file 1: FAST Treatment Record. Standardized recording
form to be used by treatment physiotherapist to document the actual
treatment time, content, repetitions of activities, the level of assistance
and feedback provided for each FAST intervention session.
Additional file 2: Active Control Treatment Record. Standardized
recording form to be used by treatment physiotherapist to document
actual treatment time, and content of Active Control intervention
sessions.
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